| Timeframe | Predicted Price | Past | Historical | Insight |
|---|---|---|---|---|
| Tomorrow | $6.35 ▼ -1.06% | Yesterday | $6.45 ▲ +0.45% | Tomorrow's DiaMedica Therapeutics Inc. Common Stock (DMAC) setup is anchored to $6.42 and targets $6.35 (-1.06%). The near-term read is downside; watch $6.61 / $6.23 because daily realized volatility is about 5.47%. |
Tomorrow's DiaMedica Therapeutics Inc. Common Stock (DMAC) setup is anchored to $6.42 and targets $6.35 (-1.06%). The near-term read is downside; watch $6.61 / $6.23 because daily realized volatility is about 5.47%. | ||||
| Week | $6.21 ▼ -3.30% | Last Week | $6.51 ▲ +1.39% | The 7-day DiaMedica Therapeutics Inc. Common Stock model moves from $6.51 to $6.21 (-3.30%). It gives downside momentum context for this stock, so breaks around $6.61 / $6.23 matter more than a single tick. |
The 7-day DiaMedica Therapeutics Inc. Common Stock model moves from $6.51 to $6.21 (-3.30%). It gives downside momentum context for this stock, so breaks around $6.61 / $6.23 matter more than a single tick. | ||||
| Month | $5.97 ▼ -7.03% | Last Month | $6.61 ▲ +2.95% | The 1-month DiaMedica Therapeutics Inc. Common Stock target is $5.97 (-7.03%), compared with the live reference near $6.42. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. |
The 1-month DiaMedica Therapeutics Inc. Common Stock target is $5.97 (-7.03%), compared with the live reference near $6.42. This horizon blends current trend pressure with price momentum, liquidity, and company-specific risk. | ||||
| Year | $5.61 ▼ -12.62% | Last Year | $6.76 ▲ +5.30% | The 1-year DiaMedica Therapeutics Inc. Common Stock scenario points to $5.61 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. |
The 1-year DiaMedica Therapeutics Inc. Common Stock scenario points to $5.61 (-12.62%). Confidence is lower than short-term rows, so treat it as cycle context and re-check it after major market-data updates. | ||||
| 5 Years | $4.77 ▼ -25.71% | 5 Years Ago | $7.11 ▲ +10.80% | The 5-year DiaMedica Therapeutics Inc. Common Stock view is $4.77 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. |
The 5-year DiaMedica Therapeutics Inc. Common Stock view is $4.77 (-25.71%). It is a directional scenario built from bounded drift and volatility, not a guaranteed path. | ||||
| Indicator | Value | Signal |
|---|---|---|
| Price | $6.42 | Mid |
| Daily Change | -2.13% | Below |
| Volatility Cap | 20.0% | Mid |
| Confidence | 62% | Below |
| Data Source | nasdaq-screener | Mid |
| Current | $6.42 | Daily Change | -2.13% |
| Market Cap | $345.43M | Source | nasdaq-screener |
Related ideas for internal navigation, grouped by stronger upside and weaker downside setups in the same market.